Table 6.

MIC distribution of BMS and ITR strains to NCCLS-recommended quality control

DrugQuality control strainNo. of tests with the following drug MIC (μg/ml)a:
0.50.250.130.060.030.015
BMS C. parapsilosis ATCC 22019[1 165]
C. krusei ATCC 22492[0513]
ITR C. parapsilosis ATCC 22019(25 16)1
C. krusei ATCC 22492(0128)1 
  • a Brackets represent proposed acceptable quality control range for BMS. Parentheses represent NCCLS-recommended acceptable quality control range for ITR.